Oxford Science Enterprises
Investor profile
Venture capital
Oxford Science Enterprises has backed 30 European tech companies across 38 funding rounds between 2022 and 2026, joining rounds totalling €1.6B. Most active in Healthtech and Cleantech. Data as of Nov 2026.
Deals
38
distinct rounds
Companies
30
backed
Active span
2022–2026
5 yrs
Total round €
€1.6B
sum of rounds joined
Deals by year
distinct rounds / yearOxford Science Enterprises — deals by year — interactive chart.
Data table
| Oxford Science Enterprises — deals by year | |
|---|---|
| 2022 | 13 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 11 |
Top sectors
by dealsOxford Science Enterprises — top sectors — interactive chart.
Data table
| Oxford Science Enterprises — top sectors | |
|---|---|
| Healthtech | 12 |
| Cleantech | 6 |
| Deeptech | 6 |
| Energy | 3 |
| AI | 2 |
| Cybersecurity | 2 |
| Semiconductors | 2 |
| Software | 2 |
| Hardware | 1 |
| Robotics | 1 |
Stages
by dealsOxford Science Enterprises — stages — interactive chart.
Data table
| Oxford Science Enterprises — stages | |
|---|---|
| Series A | 9 |
| Other | 8 |
| Series C | 7 |
| Seed | 6 |
| Series B | 6 |
| Pre-Seed | 2 |
Countries
by dealsOxford Science Enterprises — countries — interactive chart.
Data table
| Oxford Science Enterprises — countries | |
|---|---|
| UK | 37 |
| Netherlands | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- University of Oxford5
- Braavos Capital4
- British Business Bank4
- British Patient Capital4
- Lansdowne Partners4
- BGF3
- GV3
- Oxford Investment Consultants3
- Pfizer Ventures3
- Addition2
- Andera Partners2
- Bullhound Capital2
- Cambridge Innovation Capital2
- Canaan Partners2
- Chevron Technology Ventures2
- Earlybird Venture Capital2
- Hermann Hauser2
- INKEF Capital2
- IP Group2
- Kindred Capital2
- Legal & General2
- NATO Innovation Fund2
- Northpond Ventures2
- Oxford University2
- Parkwalk Advisors2
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| OMass Therapeutics | UK | 2 | €362M |
| Oxford Quantum Circuits | UK | 2 | €346M |
| Quantum Motion | UK | 1 | €136M |
| Salience Labs | UK | 2 | €123M |
| Grey Wolf Therapeutics | UK | 2 | €87M |
| Osler Diagnostics | UK | 1 | €85M |
| moa Technology Limited | UK | 2 | €67M |
| PQShield | UK | 2 | €52M |
| Ultromics | UK | 1 | €48M |
| First Light Fusion | UK | 1 | €40M |
| Nucleome Therapeutics | UK | 1 | €38M |
| FluoRok | UK | 2 | €36M |
| Oxford Ionics | UK | 1 | €34M |
| Fractile | UK | 2 | €33M |
| Scenic Biotech | Netherlands | 1 | €28M |
| Mixergy | UK | 1 | €14M |
| ORCA Computing | UK | 1 | €14M |
| Vivid Dx | UK | 1 | €13M |
| Brill Power | UK | 1 | €10M |
| Natcap | UK | 1 | €9.2M |
| Util | UK | 1 | €6.1M |
| Navenio | UK | 1 | €5.9M |
| NavLive | UK | 1 | €4.8M |
| Mirae | UK | 1 | €4.7M |
| Archangel Lightworks | UK | 1 | €4.5M |
| MCatalysis | UK | 1 | €4.3M |
| Stateful Robotics | UK | 1 | €4.1M |
| Opsydia | UK | 1 | €4.0M |
| Porpoise Power | UK | 1 | €1.4M |
| iotaSciences | UK | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Oxford Quantum Circuits | Series C | €301M | 2026-06 |
| Quantum Motion | Series C | €136M | 2026-05 |
| OMass Therapeutics | Series B | €90M | 2022-04 |
| Osler Diagnostics | Series C | €85M | 2022-11 |
| Ultromics | Series C | €48M | 2025-07 |
| Oxford Quantum Circuits | Series A | €45M | 2022-07 |
| Grey Wolf Therapeutics | Series B | €45M | 2023-01 |
| Grey Wolf Therapeutics | Series B | €42M | 2024-05 |
| moa Technology Limited | Series B | €41M | 2022-06 |
| First Light Fusion | Series C | €40M | 2022-02 |